Imugene – A possible cure for cancer? Could this be the real thing?
Listen to ASX-listed Imugene Managing Director, Leslie Chong talk to Matt Birney on the 6PR Bulls N’ Bears Report about the company’s cancer-fighting clinical trials that caused its market cap to jump from $12m to nearly a billion dollars.